FMT
NKTR icon

First Mercantile Trust’s Nektar Therapeutics NKTR Stock Holding History

First Mercantile Trust’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-118
Closed -$30K – 879
2020
Q3 		$30K Sell
118
-30
-20% -$9.44K ﹤0.01% 817
2020
Q2 		$51K Sell
148
-4
-3% -$1.25K 0.01% 776
2020
Q1 		$41K Sell
152
-5
-3% -$1.55K 0.01% 732
2019
Q4 		$51K Sell
157
-13
-8% -$3.77K 0.01% 788
2019
Q3 		$46K Sell
170
-79
-32% -$29K ﹤0.01% 826
2019
Q2 		$132K Sell
249
-28
-10% -$14K 0.01% 571
2019
Q1 		$140K Sell
277
-23
-8% -$13.6K 0.03% 573
2018
Q4 		$148K Sell
300
-93
-24% -$56.1K 0.04% 528
2018
Q3 		$359K Buy
393
+81
+26% +$69.1K 0.07% 332
2018
Q2 		$229K Buy
312
+10
+3% +$11.5K 0.05% 473
2018
Q1 		$480K Sell
302
-30
-9% -$38.6K 0.1% 256
2017
Q4 		$298K Buy
+332
New +$196K 0.06% 408
2016
Q2 		– Sell
-446
Closed -$92K – 907
2016
Q1 		$92K Sell
446
-88
-16% -$16.9K 0.01% 760
2015
Q4 		$135K Buy
+534
New +$110K 0.01% 744
2013
Q3 		– Sell
-777
Closed -$135K – 1190
2013
Q2 		$135K Buy
+777
New +$119K 0.01% 833

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

First Mercantile Trust's NKTR Position: Q4 2020 in Review

First Mercantile Trust sold out of Nektar Therapeutics (NKTR) in Q4 2020, closing a stake of 118 shares — an estimated $30K sold.

First Mercantile Trust first reported a position in NKTR in Q2 2013 and held it in 15 quarters. The position peaked at $480K in Q1 2018. 245 funds tracked by Wall St. Rank hold NKTR as of Q4 2020.

  • First Mercantile Trust reported no remaining Nektar Therapeutics position as of Q4 2020 after selling out during the quarter.
  • First Mercantile Trust sold 118 Nektar Therapeutics shares in Q4 2020, an estimated $30K.
  • First Mercantile Trust first reported a position in Nektar Therapeutics in Q2 2013 and held it in 15 quarters.
  • First Mercantile Trust's Nektar Therapeutics position peaked at $480K in Q1 2018.
  • 245 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2020.

Based on First Mercantile Trust's 13F filing for Q4 2020, filed 11 Feb 2021.